You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

List of Excipients in API glyburide and metformin hydrochloride


✉ Email this page to a colleague

« Back to Dashboard


Excipients in NDA-approved (novel) drugs containing glyburide and metformin hydrochloride

Glossary
Company Tradename Ingredient NDC Excipient Potential Generic Entry
Physicians Total Care Inc GLUCOVANCE glyburide and metformin hydrochloride 54868-4609 CELLULOSE, MICROCRYSTALLINE
Physicians Total Care Inc GLUCOVANCE glyburide and metformin hydrochloride 54868-4609 CROSCARMELLOSE SODIUM
Physicians Total Care Inc GLUCOVANCE glyburide and metformin hydrochloride 54868-4609 MAGNESIUM STEARATE
Physicians Total Care Inc GLUCOVANCE glyburide and metformin hydrochloride 54868-4609 POVIDONE
>Company >Tradename >Ingredient >NDC >Excipient >Potential Generic Entry

Subscribe to access the full database, or Sign Up

Excipients in ANDA-approved (generic) drugs containing glyburide and metformin hydrochloride

Company Ingredient NDC Excipient
Actavis Pharma Inc glyburide and metformin hydrochloride 0228-2751 AMMONIO METHACRYLATE COPOLYMER TYPE B
Actavis Pharma Inc glyburide and metformin hydrochloride 0228-2751 CELLULOSE, MICROCRYSTALLINE
Actavis Pharma Inc glyburide and metformin hydrochloride 0228-2751 CROSCARMELLOSE SODIUM
Actavis Pharma Inc glyburide and metformin hydrochloride 0228-2751 HYPROMELLOSES
>Company >Ingredient >NDC >Excipient

Subscribe to access the full database, or Sign Up

Detailed excipient profiles for glyburide and metformin hydrochloride

Excipient focus: AMMONIO METHACRYLATE COPOLYMER TYPE B

glyburide and metformin hydrochloride drug variants not containing AMMONIO METHACRYLATE COPOLYMER TYPE B

Company Ingredient NDC
A-S Medication Solutions glyburide and metformin hydrochloride 50090-0887
A-S Medication Solutions glyburide and metformin hydrochloride 50090-0888
A-S Medication Solutions glyburide and metformin hydrochloride 50090-2030
A-S Medication Solutions glyburide and metformin hydrochloride 50090-2031
>Company >Ingredient >NDC

Subscribe to access the full database, or Sign Up

Excipient focus: CALCIUM CARBONATE

Excipient focus: CELLULOSE, MICROCRYSTALLINE

Excipient focus: CROSCARMELLOSE SODIUM

Excipient focus: D&C YELLOW NO. 10

Excipient focus: FD&C BLUE NO. 2

Excipient focus: FD&C RED NO. 40

Excipient focus: FD&C YELLOW NO. 6

Excipient focus: FERRIC OXIDE RED

Excipient focus: FERRIC OXIDE YELLOW

Excipient focus: FERROSOFERRIC OXIDE

Excipient focus: HYPROMELLOSE

Excipient focus: HYPROMELLOSE 2910

Excipient focus: HYPROMELLOSES

Excipient focus: LACTOSE MONOHYDRATE

Excipient focus: MAGNESIUM STEARATE

Excipient focus: METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER

glyburide and metformin hydrochloride drug variants not containing METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER

Company Ingredient NDC
Actavis Pharma Inc glyburide and metformin hydrochloride 0228-2751
A-S Medication Solutions glyburide and metformin hydrochloride 50090-0887
A-S Medication Solutions glyburide and metformin hydrochloride 50090-0888
A-S Medication Solutions glyburide and metformin hydrochloride 50090-2030
>Company >Ingredient >NDC

Subscribe to access the full database, or Sign Up

Excipient focus: POLYDEXTROSE

Excipient focus: POLYETHYLENE GLYCOL

Excipient focus: POLYETHYLENE GLYCOL 4000

Excipient focus: POLYETHYLENE GLYCOL 6000

Excipient focus: POLYETHYLENE GLYCOLS

Excipient focus: POLYSORBATE 80

Excipient focus: POVIDONE

Excipient focus: POVIDONE K30

Excipient focus: POVIDONE K90

Excipient focus: PROPYLENE GLYCOL

Excipient focus: SILICON DIOXIDE

Excipient focus: SODIUM HYDROXIDE

Excipient focus: SODIUM STARCH GLYCOLATE TYPE A POTATO

Excipient focus: SORBIC ACID

Excipient focus: TALC

Excipient focus: TITANIUM DIOXIDE

Excipient focus: TRIACETIN

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
 NCE-1 Patent Challenge Dates 2024 - 2025
 Trigger-based marketing for the life sciences
 Get DrugPatentWatch Business Intelligence Reports at Amazon.com
 DrugChatter - AI-based answers to questions about drugs
 RxJam - Digital Marketing for Life Sciences
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
   See Primary Research Papers Citing DrugPatentWatch

Links

Follow DrugPatentWatch:

  DrugPatentWatch Linkedin Group